PTPRC and COVID-19: In addition, the intermediate monocyte compartment was substantially, yet not significantly, larger in COVID‐19 patients (median, % of CD45+ cells, moderate: 5.6 [IQR: 3.4–7.8], severe: 5.1 [IQR: 3.7–8.7]) than in control individuals (2.1 [IQR: 2–2.6]) (Figure 3).